Record Irish GDP contraction masks robust domestic economy
The CSO confirmed today that the record 12% fall in Irish GDP in Q1 2026 reflected just a small number of multinational firms in the pharmaceutical sector. The underlying story is that the surge in exports in 2025, ahead of feared US tariffs, is now unwinding in early 2026. Hence, the Irish GDP growth rate once again does not provide a meaningful guide to how the economy is performing in reality. With new pharmaceutical production facilities coming online and demand for weight-loss drugs only growing, the outlook for the sector is clearly positive. However, headline Irish GDP growth will likely be negative in 2026, albeit after the 12% rise in 2025.
Peering through the statistical fog, the domestic economy continued to perform well early in 2026. Consumer spending saw a healthy 0.6% rise, up 2.6% year-on-year. Public expenditure continued to contribute to demand, up 3.7% year-on-year. Homebuilding and the expansion of the construction sector helped to drive a 9.4% rise in investment. Overall, modified domestic demand saw a robust 0.6% rise in Q1 2026, up 4.3% on the year. This is still a faster pace than the 2.7% growth we had forecast for calendar year 2026. So the underlying message from the GDP data is that the domestic economy had a little more momentum than expected in Q1 2026.
Read the Weekly in Full Here: